Theravance Inc (NASDAQ:THRX)

16.87
Delayed Data
As of Jul 02
 -0.55 / -3.16%
Today’s Change
10.58
Today|||52-Week Range
31.80
+19.22%
Year-to-Date
No recent news for Theravance Inc.

Today’s Trading

Previous close17.42
Today’s open17.50
Day’s range16.76 - 17.50
Volume672,143
Average volume (3 months)623,640
Market cap$2.0B
Dividend yield5.93%
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+90.11%
Earnings growth (next 5 years)-464.61%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-0.35-0.51%
ADROAduro Biotech Inc+0.40+1.30%
LGNDLigand Pharmaceutica...+1.51+1.56%
GLPGGalapagos NV-1.64-3.13%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers